semaglutide prediabetes progression to diabetes trial Reversion normoglycemia with tirzepatide vs in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5 | Journal of Endocrinological Investigation Semaglutide Hype or Hope: Evidence-based

For WorldatWork Members Considerations to Manage the Costs of GLP-1 Coverage, Workspan Daily Plus+ article Total Rewards Inventory of Programs & Practices, research Total Rewards Inventory Checklist, tool Five Emerging Workplace Trends Affecting the Employee Experience, Journal of Total Rewards article For Everyone As Interest in GLP-1 Drugs Spikes, Employers Weigh the Costs, Benefits, Workspan Daily article Employers Grapple with the Rising Costs and Popularity of Specialty Weight-Loss Drugs, Workspan Daily article Most Employers Hold Firm on Well-Being Offerings But Want Results, Workspan Daily article As Health Costs Spike, Total Rewards and CFO Collaboration Is Crucial, Workspan Daily article Employers Facing Healthcare Cost Containment Challenge for 2025, Workspan Daily article Glucagon-like peptide-1 (GLP-1) medications are more top-of-mind than ever this year for employees and theyre looking to their employers to help pay for them

Being Alert to Changes in Your Routine, Diet, or Health Status Can Help You Catch and Manage Recurrences Early

The way diabetes treatment has evolved is by trying to attack all these complications with different combinations of oral and injected medications

Combining these nutrients thoughtfully can create a snack or meal that keeps you more satisfied than something mainly made from refined starches or sugar

Coviello says its important to be ready for changes in appetite

Tirzepatide (Mounjaro) for type 2 diabetes starts at 2.5 mg once weekly for four weeks, then increases to 5 mg